In these unsettling times of the COVID-19 pandemic, we at Catalyst Intellectual Property want to support the efforts that are planned or are underway in New Zealand for the development of a COVID-19 vaccine. The development of a vaccine for COVID-19 is a priority for public health. We are all in this pandemic together, and we want to do our bit to contribute. We are especially pleased to offer our services to anyone in New Zealand at no cost for the establishment of patent protection for innovations relating to COVID-19 vaccine development. The services include the preparation (drafting of patent specifications) and filing of provisional patent applications in New Zealand. If you would like to take advantage of this offer, please get in touch with your main contact at Catalyst Intellectual Property or any of Greg Lynch (greg.lynch@catalystip.co.nz), Garth Hendry (garth.hendry@catalystip.co.nz) and John Mansell (john.mansell@catalystip.co.nz).
Search
Recent Posts
See AllThe KiwiNet Research Commercialisation Awards is New Zealand’s premier event celebrating the achievements of New Zealand individuals, teams and organisations actively commercialising publicly funded r
C-Prize is a bi-annual technology challenge initiative from Callaghan Innovation that asks innovators to develop industry-changing solutions to complex global problems. This year the competition was f
Increases to official fees will come into effect for Australian IP rights, including patents, trade marks and designs on 1 October 2020. The official announcement and full list of fee changes can be f